|

68Ga-NNS309 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Novartis Pharmaceuticals1

Indications

  • HR+/HER2- Ductal and Lobular Breast Cancer1
  • Pancreatic Ductal Adenocarcinoma1
  • Soft Tissue Sarcoma1
  • Triple Negative Breast Cancer1
  • Colorectal Cancer1

Other1 trial

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.